Washington, Jan 28 (ANI): Taking alli (orlistat 60 mg) with a reduced calorie, lower-fat diet can lead to a significant reduction not only in weight but also in dangerous visceral fat.

alli is the only FDA-approved OTC weight loss aid that is clinically proven to boost weight loss by 50 percent and significantly reduce excess visceral fat.

Working in the digestive tract, alli prevents about 25 percent of the fat that a person eats from being absorbed.

Visceral fat is a dangerous type of fat that surrounds the vital organs in the abdomen and when present in excess disrupts the normal functioning of organs, increasing the risk of life-threatening diseases.

Even modest weight loss can result in significant reductions in visceral fat and substantially improve health.

In fact, when losing weight, visceral fat is among the first fat lost, which is associated with noticeable health benefits such as reductions in total cholesterol and low-density lipoprotein (LDL).

This helps reduce the risk of type 2 diabetes, hypertension, heart disease and stroke.4-9 It is these health complications that have a high personal and societal toll and impact in the global obesity epidemic.

“Although most individuals try to lose weight to improve their appearance, it’s important to help them understand that losing excess fat reduces their risks of life-threatening diseases,” said Jeanine Albu, Senior Attending in Medicine, Associate Chief of the Division of Endocrinology, Diabetes and Nutrition and the Chief of the Metabolism and Diabetes Clinic at the St. Luke’s-Roosevelt Hospital Center in New York.

“We need to raise awareness of the direct link between visceral fat on the inside and heart disease and diabetes. Through healthy eating, keeping active and treatments such as alli, people can lose 5 to 10 percent of total body weight - including visceral fat - and achieve and maintain their healthy weight,” Dr. Albu said

The studies were presented at the 1st International Congress on Abdominal Obesity in Hong Kong. (ANI)